Multicentric	B:C1334815
Castleman	I:C1334815
disease	I:C1334815
of	O
hyaline	O
vascular	O
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	O
report	I:C0007320
Castleman	O
disease	I:C1334815
is	O
a	O
rare	O
lymphoproliferative	O
disorder	I:C0024314
presenting	O
with	O
localized	O
or	O
disseminated	O
lymphadenopathy	O
and	O
systemic	O
manifestations	O
.	O

Multicentric	O
Castleman	I:C1334815
disease	I:C1334815
of	O
hyaline	B:C0020191
vascular	O
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	O
report	I:C0007320
Castleman	O
disease	I:C1334815
is	O
a	O
rare	O
lymphoproliferative	O
disorder	I:C0024314
presenting	O
with	O
localized	O
or	O
disseminated	O
lymphadenopathy	O
and	O
systemic	O
manifestations	O
.	O

Multicentric	O
Castleman	I:C1334815
disease	I:C1334815
of	O
hyaline	O
vascular	B:C0005847
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	O
report	I:C0007320
Castleman	O
disease	I:C1334815
is	O
a	O
rare	O
lymphoproliferative	O
disorder	I:C0024314
presenting	O
with	O
localized	O
or	O
disseminated	O
lymphadenopathy	O
and	O
systemic	O
manifestations	O
.	O

Multicentric	O
Castleman	I:C1334815
disease	I:C1334815
of	O
hyaline	O
vascular	O
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	B:C0007320
report	I:C0007320
Castleman	O
disease	I:C1334815
is	O
a	O
rare	O
lymphoproliferative	O
disorder	I:C0024314
presenting	O
with	O
localized	O
or	O
disseminated	O
lymphadenopathy	O
and	O
systemic	O
manifestations	O
.	O

Multicentric	O
Castleman	I:C1334815
disease	I:C1334815
of	O
hyaline	O
vascular	O
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	O
report	I:C0007320
Castleman	B:C1334815
disease	I:C1334815
is	O
a	O
rare	O
lymphoproliferative	O
disorder	I:C0024314
presenting	O
with	O
localized	O
or	O
disseminated	O
lymphadenopathy	O
and	O
systemic	O
manifestations	O
.	O

Multicentric	O
Castleman	I:C1334815
disease	I:C1334815
of	O
hyaline	O
vascular	O
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	O
report	I:C0007320
Castleman	O
disease	I:C1334815
is	O
a	O
rare	O
lymphoproliferative	B:C0024314
disorder	I:C0024314
presenting	O
with	O
localized	O
or	O
disseminated	O
lymphadenopathy	O
and	O
systemic	O
manifestations	O
.	O

Multicentric	O
Castleman	I:C1334815
disease	I:C1334815
of	O
hyaline	O
vascular	O
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	O
report	I:C0007320
Castleman	O
disease	I:C1334815
is	O
a	O
rare	O
lymphoproliferative	O
disorder	I:C0024314
presenting	O
with	O
localized	B:C0392752
or	O
disseminated	O
lymphadenopathy	O
and	O
systemic	O
manifestations	O
.	O

Multicentric	O
Castleman	I:C1334815
disease	I:C1334815
of	O
hyaline	O
vascular	O
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	O
report	I:C0007320
Castleman	O
disease	I:C1334815
is	O
a	O
rare	O
lymphoproliferative	O
disorder	I:C0024314
presenting	O
with	O
localized	O
or	O
disseminated	B:C0205221
lymphadenopathy	O
and	O
systemic	O
manifestations	O
.	O

Multicentric	O
Castleman	I:C1334815
disease	I:C1334815
of	O
hyaline	O
vascular	O
variant	O
presenting	O
with	O
unusual	O
systemic	O
manifestations	O
:	O
a	O
case	O
report	I:C0007320
Castleman	O
disease	I:C1334815
is	O
a	O
rare	O
lymphoproliferative	O
disorder	I:C0024314
presenting	O
with	O
localized	O
or	O
disseminated	O
lymphadenopathy	B:C0497156
and	O
systemic	O
manifestations	O
.	O

It	O
can	O
be	O
categorized	B:C0008902
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	O
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	O
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	B:C0017531
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	O
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	O
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	B:C1334815
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	O
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	O
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	B:C0020191
-	O
vascular	O
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	O
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	B:C0005847
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	O
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	O
,	O
plasma	B:C0032112
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	O
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	O
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	B:C0449411
viral	O
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	O
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	B:C0042769
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	O
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	O
infections	I:C0042769
(	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	O
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	O
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	B:C0376526
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	O
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

It	O
can	O
be	O
categorized	O
in	O
numerous	O
ways	O
,	O
such	O
as	O
unicentric	O
versus	O
multicentric	O
,	O
histopathological	O
variants	O
(	O
hyaline	O
-	O
vascular	O
,	O
plasma	O
cell	I:C0032112
,	O
and	O
mixed	O
)	O
,	O
or	O
subtypes	O
based	O
on	O
causative	O
viral	O
infections	I:C0042769
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
,	O
human	O
herpesvirus	I:C0376526
-	I:C0376526
8	I:C0376526
,	O
or	O
Kaposi	B:C0376526
sarcoma	I:C0376526
herpesvirus	I:C0376526
)	O
.	O

Presentation	O
ranges	O
from	O
asymptomatic	B:C0231221
to	O
symptoms	O
involving	O
multiple	O
organs	O
.	O

Presentation	O
ranges	O
from	O
asymptomatic	O
to	O
symptoms	B:C1457887
involving	O
multiple	O
organs	O
.	O

Presentation	O
ranges	O
from	O
asymptomatic	O
to	O
symptoms	O
involving	O
multiple	O
organs	B:C0178784
.	O

Even	O
though	O
the	O
exact	O
mechanism	O
of	O
pathogenesis	B:C0699748
is	O
unknown	O
,	O
treatment	O
is	O
directed	O
toward	O
possible	O
etiologies	O
such	O
as	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
cluster	O
of	I:C0054946
differentiation	I:C0054946
20	I:C0054946
,	O
and	O
viral	O
agents	O
.	O

Even	O
though	O
the	O
exact	O
mechanism	O
of	O
pathogenesis	O
is	O
unknown	O
,	O
treatment	O
is	O
directed	O
toward	O
possible	O
etiologies	O
such	O
as	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
,	O
cluster	O
of	I:C0054946
differentiation	I:C0054946
20	I:C0054946
,	O
and	O
viral	O
agents	O
.	O

Even	O
though	O
the	O
exact	O
mechanism	O
of	O
pathogenesis	O
is	O
unknown	O
,	O
treatment	O
is	O
directed	O
toward	O
possible	O
etiologies	O
such	O
as	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
cluster	B:C0054946
of	I:C0054946
differentiation	I:C0054946
20	I:C0054946
,	O
and	O
viral	O
agents	O
.	O

A	O
36	O
-	O
year	O
-	O
old	O
Sri	B:C1553327
Lankan	I:C1553327
woman	O
presented	O
with	O
generalized	O
body	O
swelling	I:C0577596
and	O
foamy	O
urine	O
of	O
2	O
weeks	O
'	O
duration	O
.	O

A	O
36	O
-	O
year	O
-	O
old	O
Sri	O
Lankan	I:C1553327
woman	B:C0043210
presented	O
with	O
generalized	O
body	O
swelling	I:C0577596
and	O
foamy	O
urine	O
of	O
2	O
weeks	O
'	O
duration	O
.	O

A	O
36	O
-	O
year	O
-	O
old	O
Sri	O
Lankan	I:C1553327
woman	O
presented	O
with	O
generalized	O
body	B:C0577596
swelling	I:C0577596
and	O
foamy	O
urine	O
of	O
2	O
weeks	O
'	O
duration	O
.	O

Examination	B:C0582103
revealed	O
pallor	O
;	O
generalized	O
edema	I:C1850534
;	O
axillary	O
,	O
cervical	O
,	O
and	O
inguinal	O
lymphadenopathy	I:C0578736
;	O
hypertension	O
;	O
and	O
hepatomegaly	O
.	O

Examination	O
revealed	O
pallor	B:C0030232
;	O
generalized	O
edema	I:C1850534
;	O
axillary	O
,	O
cervical	O
,	O
and	O
inguinal	O
lymphadenopathy	I:C0578736
;	O
hypertension	O
;	O
and	O
hepatomegaly	O
.	O

Examination	O
revealed	O
pallor	O
;	O
generalized	B:C1850534
edema	I:C1850534
;	O
axillary	O
,	O
cervical	O
,	O
and	O
inguinal	O
lymphadenopathy	I:C0578736
;	O
hypertension	O
;	O
and	O
hepatomegaly	O
.	O

Examination	O
revealed	O
pallor	O
;	O
generalized	O
edema	I:C1850534
;	O
axillary	B:C0004454
,	O
cervical	O
,	O
and	O
inguinal	O
lymphadenopathy	I:C0578736
;	O
hypertension	O
;	O
and	O
hepatomegaly	O
.	O

Examination	O
revealed	O
pallor	O
;	O
generalized	O
edema	I:C1850534
;	O
axillary	O
,	O
cervical	B:C0205064
,	O
and	O
inguinal	O
lymphadenopathy	I:C0578736
;	O
hypertension	O
;	O
and	O
hepatomegaly	O
.	O

Examination	O
revealed	O
pallor	O
;	O
generalized	O
edema	I:C1850534
;	O
axillary	O
,	O
cervical	O
,	O
and	O
inguinal	B:C0578736
lymphadenopathy	I:C0578736
;	O
hypertension	O
;	O
and	O
hepatomegaly	O
.	O

Examination	O
revealed	O
pallor	O
;	O
generalized	O
edema	I:C1850534
;	O
axillary	O
,	O
cervical	O
,	O
and	O
inguinal	O
lymphadenopathy	I:C0578736
;	O
hypertension	B:C0020538
;	O
and	O
hepatomegaly	O
.	O

Examination	O
revealed	O
pallor	O
;	O
generalized	O
edema	I:C1850534
;	O
axillary	O
,	O
cervical	O
,	O
and	O
inguinal	O
lymphadenopathy	I:C0578736
;	O
hypertension	O
;	O
and	O
hepatomegaly	B:C0019209
.	O

Investigations	B:C1261322
showed	O
bicytopenia	O
,	O
nephrotic	O
range	I:C0445118
proteinuria	I:C0445118
with	O
hypoalbuminemia	O
,	O
hypogammaglobulinemia	O
,	O
and	O
features	O
of	O
hyaline	O
-	O
vascular	O
type	O
Castleman	O
disease	I:C1334815
in	O
a	O
lymph	O
node	I:C0193842
biopsy	I:C0193842
.	O

Investigations	O
showed	O
bicytopenia	B:C1142446
,	O
nephrotic	O
range	I:C0445118
proteinuria	I:C0445118
with	O
hypoalbuminemia	O
,	O
hypogammaglobulinemia	O
,	O
and	O
features	O
of	O
hyaline	O
-	O
vascular	O
type	O
Castleman	O
disease	I:C1334815
in	O
a	O
lymph	O
node	I:C0193842
biopsy	I:C0193842
.	O

Investigations	O
showed	O
bicytopenia	O
,	O
nephrotic	B:C0445118
range	I:C0445118
proteinuria	I:C0445118
with	O
hypoalbuminemia	O
,	O
hypogammaglobulinemia	O
,	O
and	O
features	O
of	O
hyaline	O
-	O
vascular	O
type	O
Castleman	O
disease	I:C1334815
in	O
a	O
lymph	O
node	I:C0193842
biopsy	I:C0193842
.	O

Investigations	O
showed	O
bicytopenia	O
,	O
nephrotic	O
range	I:C0445118
proteinuria	I:C0445118
with	O
hypoalbuminemia	B:C0239981
,	O
hypogammaglobulinemia	O
,	O
and	O
features	O
of	O
hyaline	O
-	O
vascular	O
type	O
Castleman	O
disease	I:C1334815
in	O
a	O
lymph	O
node	I:C0193842
biopsy	I:C0193842
.	O

Investigations	O
showed	O
bicytopenia	O
,	O
nephrotic	O
range	I:C0445118
proteinuria	I:C0445118
with	O
hypoalbuminemia	O
,	O
hypogammaglobulinemia	B:C0086438
,	O
and	O
features	O
of	O
hyaline	O
-	O
vascular	O
type	O
Castleman	O
disease	I:C1334815
in	O
a	O
lymph	O
node	I:C0193842
biopsy	I:C0193842
.	O

Investigations	O
showed	O
bicytopenia	O
,	O
nephrotic	O
range	I:C0445118
proteinuria	I:C0445118
with	O
hypoalbuminemia	O
,	O
hypogammaglobulinemia	O
,	O
and	O
features	O
of	O
hyaline	B:C0020191
-	O
vascular	O
type	O
Castleman	O
disease	I:C1334815
in	O
a	O
lymph	O
node	I:C0193842
biopsy	I:C0193842
.	O

Investigations	O
showed	O
bicytopenia	O
,	O
nephrotic	O
range	I:C0445118
proteinuria	I:C0445118
with	O
hypoalbuminemia	O
,	O
hypogammaglobulinemia	O
,	O
and	O
features	O
of	O
hyaline	O
-	O
vascular	B:C0005847
type	O
Castleman	O
disease	I:C1334815
in	O
a	O
lymph	O
node	I:C0193842
biopsy	I:C0193842
.	O

Investigations	O
showed	O
bicytopenia	O
,	O
nephrotic	O
range	I:C0445118
proteinuria	I:C0445118
with	O
hypoalbuminemia	O
,	O
hypogammaglobulinemia	O
,	O
and	O
features	O
of	O
hyaline	O
-	O
vascular	O
type	O
Castleman	B:C1334815
disease	I:C1334815
in	O
a	O
lymph	O
node	I:C0193842
biopsy	I:C0193842
.	O

Investigations	O
showed	O
bicytopenia	O
,	O
nephrotic	O
range	I:C0445118
proteinuria	I:C0445118
with	O
hypoalbuminemia	O
,	O
hypogammaglobulinemia	O
,	O
and	O
features	O
of	O
hyaline	O
-	O
vascular	O
type	O
Castleman	O
disease	I:C1334815
in	O
a	O
lymph	B:C0193842
node	I:C0193842
biopsy	I:C0193842
.	O

She	O
was	O
managed	B:C0086583
with	O
rituximab	O
and	O
had	O
good	O
clinical	O
improvement	O
.	O

She	O
was	O
managed	O
with	O
rituximab	B:C0393022
and	O
had	O
good	O
clinical	O
improvement	O
.	O

Castleman	B:C1334815
disease	I:C1334815
has	O
a	O
broad	O
spectrum	O
of	O
clinical	O
manifestations	O
,	O
disease	O
pathogeneses	O
,	O
and	O
associations	O
and	O
/	O
or	O
complications	O
.	O

Castleman	O
disease	I:C1334815
has	O
a	O
broad	B:C0332464
spectrum	O
of	O
clinical	O
manifestations	O
,	O
disease	O
pathogeneses	O
,	O
and	O
associations	O
and	O
/	O
or	O
complications	O
.	O

Castleman	O
disease	I:C1334815
has	O
a	O
broad	O
spectrum	O
of	O
clinical	O
manifestations	O
,	O
disease	B:C0012634
pathogeneses	O
,	O
and	O
associations	O
and	O
/	O
or	O
complications	O
.	O

Castleman	O
disease	I:C1334815
has	O
a	O
broad	O
spectrum	O
of	O
clinical	O
manifestations	O
,	O
disease	O
pathogeneses	B:C0699748
,	O
and	O
associations	O
and	O
/	O
or	O
complications	O
.	O

Castleman	O
disease	I:C1334815
has	O
a	O
broad	O
spectrum	O
of	O
clinical	O
manifestations	O
,	O
disease	O
pathogeneses	O
,	O
and	O
associations	O
and	O
/	O
or	O
complications	B:C0009566
.	O

Medical	O
professionals	B:C1704312
need	O
to	O
be	O
familiar	O
with	O
this	O
spectrum	O
because	O
timely	O
diagnosis	O
and	O
aggressive	O
targeted	I:C2985566
therapy	I:C2985566
are	O
the	O
cornerstones	O
of	O
managing	O
these	O
patients	O
.	O

Medical	O
professionals	O
need	O
to	O
be	O
familiar	O
with	O
this	O
spectrum	O
because	O
timely	O
diagnosis	B:C0011900
and	O
aggressive	O
targeted	I:C2985566
therapy	I:C2985566
are	O
the	O
cornerstones	O
of	O
managing	O
these	O
patients	O
.	O

Medical	O
professionals	O
need	O
to	O
be	O
familiar	O
with	O
this	O
spectrum	O
because	O
timely	O
diagnosis	O
and	O
aggressive	B:C2985566
targeted	I:C2985566
therapy	I:C2985566
are	O
the	O
cornerstones	O
of	O
managing	O
these	O
patients	O
.	O

